HRT Financial’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,385
Closed -$114K 3306
2022
Q3
$114K Hold
11,385
﹤0.01% 2182
2022
Q2
$114K Hold
11,385
﹤0.01% 2329
2022
Q1
$112K Hold
11,385
﹤0.01% 2369
2021
Q4
$113K Hold
11,385
﹤0.01% 2443
2021
Q3
$113K Hold
11,385
﹤0.01% 2599
2021
Q2
$116K Hold
11,385
﹤0.01% 2458
2021
Q1
$115K Hold
11,385
﹤0.01% 2212
2020
Q4
$121K Buy
+11,385
New +$121K ﹤0.01% 1535